Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study

Laurel A. Habel, Wei Zhao, Janet L. Stanford, Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes & Control. ,vol. 13, pp. 427- 434 ,(2002) , 10.1023/A:1015788502099

Tsung-Yun Liu, Chin-Wen Chi, Chin-Chen Pan, Liang-Ming Lee, Chien-Jui Cheng, Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia. Anticancer Research. ,vol. 21, pp. 1291- 1294 ,(2001)

Steven R. Patierno, Fadwa A. Attiga, Michael J. Manyak, Patricia M. Fernandez, Ashani T. Weeraratna, Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Research. ,vol. 60, pp. 4629- 4637 ,(2000)

S. Madaan, P.D. Abel, K.S. Chaudhary, R. Hewitt, M.A. Stott, G.W.H. Stamp, E.-N. Lalani, Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment BJUI. ,vol. 86, pp. 736- 741 ,(2001) , 10.1046/J.1464-410X.2000.00867.X

John Andrews, Daniel Djakiew, Scott Krygier, Peter Andrews, Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells. Cancer Chemotherapy and Pharmacology. ,vol. 50, pp. 277- 284 ,(2002) , 10.1007/S00280-002-0485-8

Philip C Prorok, Gerald L Andriole, Robert S Bresalier, Saundra S Buys, David Chia, E David Crawford, Ronald Fogel, Edward P Gelmann, Fred Gilbert, Marsha A Hasson, Richard B Hayes, Christine Cole Johnson, Jack S Mandel, Albert Oberman, Barbara O'Brien, Martin M Oken, Sameer Rafla, Douglas Reding, Wilmer Rutt, Joel L Weissfeld, Lance Yokochi, John K Gohagan, FACE for the PLCO Project Team, Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial Controlled Clinical Trials. ,vol. 21, pp. 273- ,(2000) , 10.1016/S0197-2456(00)00098-2

S Friis, H T Sørensen, J K McLaughlin, S P Johnsen, W J Blot, J H Olsen, A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin British Journal of Cancer. ,vol. 88, pp. 684- 688 ,(2003) , 10.1038/SJ.BJC.6600760

E. J. Jacobs, C. Rodriguez, E. B. Bain, Y. Wang, M. J. Thun, E. E. Calle, Cholesterol-Lowering Drugs and Advanced Prostate Cancer Incidence in a Large U.S. Cohort Cancer Epidemiology, Biomarkers & Prevention. ,vol. 16, pp. 2213- 2217 ,(2007) , 10.1158/1055-9965.EPI-07-0448

Salaheddin M. Mahmud, Eduardo L. Franco, Armen G. Aprikian, Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis. International Journal of Cancer. ,vol. 127, pp. 1680- 1691 ,(2010) , 10.1002/IJC.25186

H T Sørensen, S Friis, B Nørgård, L Mellemkjær, W J Blot, J K McLaughlin, A Ekbom, J A Baron, Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study British Journal of Cancer. ,vol. 88, pp. 1687- 1692 ,(2003) , 10.1038/SJ.BJC.6600945